Anti-ischemic actions of a new throm☐ane receptor antagonist during acute myocardial ischemia in cats

This publication has 19 references indexed in Scilit:

• Preservation of ischemic myocardial tissue with an antagonist of vasoconstrictor eicosanoids
  Canadian Journal of Physiology and Pharmacology, 1984
• The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug
  Thrombosis Research, 1984
• BM 13.177, A SELECTIVE BLOCKER OF PLATELET AND VESSEL WALL THROMBOXANE RECEPTORS, IS ACTIVE IN MAN
  The Lancet, 1984
• Protection of Ischemic Cat Myocardium By CGS-13080, a Selective Potent Thromboxane A2 Synthesis Inhibitor
  Journal of Cardiovascular Pharmacology, 1983
• Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1983
• Role of prostacyclin in the preservation of ischemic myocardial tissue in the perfused cat heart.
  Circulation Research, 1980
• Salvage of ischemic myocardium by ibuprofen during infarction in the conscious dog
  The American Journal of Cardiology, 1980
• Influence of thromboxane inhibition on the severity of myocardial ischemia in cats
  Canadian Journal of Physiology and Pharmacology, 1980
• Cardiac and Coronary Prostaglandin Synthesis and Function
  New England Journal of Medicine, 1978
• Coronary Arterial Smooth Muscle Contraction by a Substance Released from Platelets: Evidence That It Is Thromboxane A ₂
  Science, 1976